Doctors, Lay Down Your Egos

If you’ve been paying attention to the healthcare news lately you might have heard that the genetics testing company 23andme has put a halt to their testing at the request of the FDA.  The official reasoning?  The FDA feels they “still do not have any assurance that the firm has analytically or clinically validated the … Continue reading

The Genetics and Intellectual Property Battle Rages On

Today marks another moment in the debate between burgeoning genetics companies trying to establish themselves in a growing industry and the American public, who is really just beginning to understand what genetics actually is. It wasn’t too long ago (2000) that the first genome had actually been mapped by J. Craig Venter’s team at Applera … Continue reading